Inovio Pharmaceuticals
INO
#9807
Rank
S$0.10 B
Marketcap
S$1.28
Share price
-2.88%
Change (1 day)
-35.80%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -S$0.12 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.12 Billion, an increase over its 2024 earnings that were of -S$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.12 Billion-3.99%
2025 -S$0.12 Billion-15.67%
2024 -S$0.14 Billion-20.03%
2023 -S$0.18 Billion-51.56%
2022 -S$0.36 Billion-8.26%
2021 -S$0.39 Billion95.4%
2020 -S$0.2 Billion36.62%
2019 -S$0.15 Billion20.19%
2018 -S$0.13 Billion10.94%
2017 -S$0.11 Billion9.59%
2016 -S$99.73 Million118.9%
2015 -S$45.56 Million-10.67%
2014 -S$51 Million83.32%
2013 -S$27.82 Million
2011 -S$28.7 Million15.64%
2010 -S$24.82 Million37.7%
2009 -S$18.03 Million2.19%
2008 -S$17.64 Million-14.09%
2007 -S$20.53 Million19.12%
2006 -S$17.24 Million9.62%
2005 -S$15.72 Million5.77%
2004 -S$14.87 Million73.08%
2003 -S$8.59 Million12.75%
2002 -S$7.62 Million
2000 -S$11.53 Million53.93%
1999 -S$7.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.54 B-29,892.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.37 B-18,200.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.67 B-12,245.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$13.85 B-12,402.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.98 B-15,182.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.92 B-11,580.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-S$3.56 Million-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-S$0.21 Billion 83.29%๐Ÿ‡บ๐Ÿ‡ธ USA